Showing results (1-10 of 136) with videos related to
Sort By:
Pageof 14
Nature|May 21, 1992
An immunological role for the CD8 beta-chainC J Wheeler, P von Hoegen, J R ParnesProceedings of the National Academy of Sciences of the United States of America|April 1, 1991
Adhesion versus coreceptor function of CD4 and CD8: role of the cytoplasmic tail in coreceptor activityM C Miceli, P von Hoegen, J R ParnesThe Journal of Experimental Medicine|December 1, 1989
Equivalence of human and mouse CD4 in enhancing antigen responses by a mouse class II-restricted T cell hybridomaP von Hoegen, M C Miceli, B Tourvieille, et al.Immunology Letters|September 1, 1995
Synergistic role of type I interferons in the induction of protective cytotoxic T lymphocytesP von HoegenAdvanced Drug Delivery Reviews|August 23, 2001
Synthetic biomimetic supra molecular Biovector (SMBV) particles for nasal vaccine deliveryP von HoegenNature|November 16, 1989
Inability of CD8 alpha' polypeptides to associate with p56lck correlates with impaired function in vitro and lack of expression in vivoR Zamoyska, P Derham, S D Gorman, et al.Journal of Immunology (Baltimore, Md. : 1950)|May 9, 1998
Mechanisms of CD8beta-mediated T cell response enhancement: interaction with MHC class I/beta2-microglobulin and functional coupling to TCR/CD3C J Wheeler, J Y Chen, T A Potter, et al.European Journal of Immunology|August 1, 1988
Modification of tumor cells by a low dose of Newcastle disease virus. Augmentation of the tumor-specific T cell response in the absence of an anti-viral responseP Von Hoegen, E Weber, V SchirrmacherInternational Journal of Cancer|July 15, 1994
Scattered micrometastases visualized at the single-cell level: detection and re-isolation of lacZ-labeled metastasized lymphoma cellsA Krüger, V Schirrmacher, P von HoegenInternational Journal of Cancer|November 15, 1986
Immunoresistant metastatic tumor variants can re-express their tumor antigen after treatment with DNA methylation-inhibiting agentsP Altevogt, P von Hoegen, V SchirrmacherPageof 14